Enns B, Krebs E, DeBeck K, Hayashi K, Milloy MJ, Richardson L, Wood E, Nosyk B The costs of crime associated with stimulant use in a Canadian setting Drug Alcohol Depend PubMed

Panagiotoglou D, Krebs E, Min JE, Olding M, Ahamad K, Ti L, Montaner JSG, Nosyk B Initiating HCV treatment with direct acting agents in opioid agonist treatment: when to start for people co-infected with HIV? Int J Drug Policy PubMed

Krebs E, Min JE, Evans E, Li L, Liu L, Huang YC, Urada D, Kerr T, Hser YI, Nosyk B Estimating state transitions for opioid use disorders Med Decis Making PubMed

Krebs E, Wang L, Olding M, DeBeck K, Hayashi K, Milloy MJ, Wood E, Nosyk B, Richardson L Increased drug use and the timing of social assistance receipt among people who use illicit drugs Soc Sci Med PubMed

Krebs E, Kerr T, Wood E, Nosyk B Characterizing long-term health related quality of life trajectories of individuals with opioid use disorder J Subst Abuse Treat PubMed

Nosyk B, Krebs E, Min JE, Ahamad K, Buxton J, Goldsmith C, Hull M, Joe R, Krajden M, Lima VD, Olding M, Wood E, Montaner JS The 'Expanded HIV care in Opioid Substitution Treatment' (EHOST) cluster-randomized, stepped-wedge trial: a study protocol Contemp Clin Trials PubMed

Krebs E, Kerr T, Montaner J, Wood E, Nosyk B Dynamics in the costs of criminality among opioid dependent individuals Drug and Alcohol Dependence PubMed